AAAAAA
Results: 1-25/65
Authors:
BERNTORP E
Citation: E. Berntorp, GUIDELINES ON TREATMENT OF HEMOPHILIA IN SWEDEN, Haemophilia, 4(4), 1998, pp. 425-426
Authors:
SZUCS TD
OFFNER A
KRONER B
GIANGRANDE P
BERNTORP E
SCHRAMM W
Citation: Td. Szucs et al., RESOURCE UTILIZATION IN HEMOPHILIACS TREATED IN EUROPE - RESULTS FROMTHE EUROPEAN STUDY ON SOCIOECONOMIC ASPECTS OF HEMOPHILIA CARE, Haemophilia, 4(4), 1998, pp. 498-501
Authors:
BERNTORP E
ASTERMARK J
JURGUTIS R
LETHAGEN S
PETERSSON C
Citation: E. Berntorp et al., THE MALMO-KLAIPEDA WFH TWINNING PROGRAM - A COMPARATIVE DESCRIPTION OF THE HEMOPHILIA COHORTS, Haemophilia, 4(2), 1998, pp. 79-82
Authors:
CARLSSON M
BJORKMAN S
BERNTORP E
Citation: M. Carlsson et al., MULTIDOSE PHARMACOKINETICS OF FACTOR-IX - IMPLICATIONS FOR DOSING IN PROPHYLAXIS, Haemophilia, 4(2), 1998, pp. 83-88
Authors:
FREIBURGHAUS C
BERNTORP E
EKMAN M
GUNNARSSON M
KJELLBERG BM
NILSSON IM
Citation: C. Freiburghaus et al., IMMUNOADSORPTION FOR REMOVAL OF INHIBITORS - UPDATE ON TREATMENTS IN MALMO-LUND BETWEEN 1980 AND 1995, Haemophilia, 4(1), 1998, pp. 16-20
Authors:
TENGBORN L
BERNTORP E
Citation: L. Tengborn et E. Berntorp, CONTINUOUS-INFUSION OF FACTOR-IX CONCENTRATE TO INDUCE IMMUNE TOLERANCE IN 2 PATIENTS WITH HEMOPHILIA-B, Haemophilia, 4(1), 1998, pp. 56-59
Authors:
ASTERMARK J
BJORGELL O
LINDEN E
LETHAGEN S
NILSSON P
BERNTORP E
Citation: J. Astermark et al., LOW RECURRENCE RATE AFTER DEEP CALF-VEIN THROMBOSIS WITH 6 WEEKS OF ORAL ANTICOAGULATION, Journal of internal medicine, 244(1), 1998, pp. 79-82
Authors:
BERNTORP E
BERNTORP K
BRORSON H
FRICK K
Citation: E. Berntorp et al., LIPOSUCTION IN DERCUMS-DISEASE - IMPACT ON HEMOSTATIC FACTORS ASSOCIATED WITH CARDIOVASCULAR-DISEASE AND INSULIN SENSITIVITY, Journal of internal medicine, 243(3), 1998, pp. 197-201
Authors:
MATTIASSON I
BERNTORP E
BORNHOV S
LAGERSTEDT C
LETHAGEN S
PERSSON J
TIMBERG I
TORSTENSSON I
Citation: I. Mattiasson et al., OUTPATIENT TREATMENT OF ACUTE DEEP-VEIN THROMBOSIS, International angiology, 17(3), 1998, pp. 146-150
Authors:
HOLM J
TODT T
BERNTORP E
ERHARDT L
Citation: J. Holm et al., FAILURE OF THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL-INFARCTION IS ASSOCIATED WITH HIGH PLASMA-LEVELS OF FACTOR-VII ANTIGEN, Thrombosis and haemostasis, 79(5), 1998, pp. 928-931
Authors:
HAY CRM
LUDLAM CA
COLVIN BT
HILL FGH
PRESTON FE
WASSEEM N
BAGNALL R
PEAKE IR
BERNTORP E
BUNSCHOTEN EPM
FIJNVANDRAAT K
KASPER CK
WHITE G
SANTAGOSTINO E
Citation: Crm. Hay et al., FACTOR-VIII INHIBITORS IN MILD AND MODERATE-SEVERITY HEMOPHILIA-A, Thrombosis and haemostasis, 79(4), 1998, pp. 762-766
Authors:
ASTERMARK T
LOFQVIST T
SCHULMAN S
STIGENDAL L
LETHAGEN S
NILSSON IH
BERNTORP E
Citation: T. Astermark et al., MAJOR SURGERY SEEMS NOT TO INFLUENCE HIV DISEASE PROGRESSION IN HEMOPHILIA PATIENTS, British Journal of Haematology, 103(1), 1998, pp. 10-14
Authors:
ASTERMARK J
JOHNSSON H
STIGENDAL L
LETHAGEN S
BERNTORP E
Citation: J. Astermark et al., HIV-DISEASE PROGRESSION IN SWEDISH HEMOPHILIACS AND THE INFLUENCE OF REPLACEMENT THERAPY, Haemophilia, 3(4), 1997, pp. 277-282
Authors:
CARLSSON M
BERNTORP E
BJORKMAN S
LETHAGEN S
LJUNG R
Citation: M. Carlsson et al., IMPROVED COST-EFFECTIVENESS BY PHARMACOKINETIC DOSING OF FACTOR-VIII IN PROPHYLACTIC TREATMENT OF HAEMOPHILIA-A, Haemophilia, 3(2), 1997, pp. 96-101
Authors:
LOFQVIST T
NILSSON IM
BERNTORP E
PETTERSSON H
Citation: T. Lofqvist et al., HEMOPHILIA PROPHYLAXIS IN YOUNG-PATIENTS - A LONG-TERM FOLLOW-UP, Journal of internal medicine, 241(5), 1997, pp. 395-400
Authors:
TENGBORN L
BERNTORP E
Citation: L. Tengborn et E. Berntorp, CONTINUOUS-INFUSION OF FACTOR-IX CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN 2 PATIENTS WITH HEMOPHILIA-B, Thrombosis and haemostasis, 1997, pp. 213-213
Authors:
LINDGREN A
STIGENDAL L
TENGBORN L
JOHNSSON H
BERNTORP E
Citation: A. Lindgren et al., ON ACQUIRED HEMOPHILIA-A IN SWEDEN, Thrombosis and haemostasis, 1997, pp. 875-875
Authors:
ASTERMARK J
BERNTORP E
Citation: J. Astermark et E. Berntorp, PROPHYLACTIC TREATMENT OF HEMOPHILIACS - WHEN TO START AND HOW TO DOSE, Thrombosis and haemostasis, 1997, pp. 1000-1000
Authors:
BERNTORP E
Citation: E. Berntorp, 2ND-GENERATION, B-DOMAIN DELETED RECOMBINANT FACTOR-VIII, Thrombosis and haemostasis, 78(1), 1997, pp. 256-260
Authors:
FIJNVANDRAAT K
BERNTORP E
TENCATE JW
JOHNSSON H
PETERS M
SAVIDGE G
TENGBORN L
SPIRA J
STAHL C
Citation: K. Fijnvandraat et al., RECOMBINANT, B-DOMAIN DELETED FACTOR-VIII (R-VIII SQ) - PHARMACOKINETICS AND INITIAL SAFETY ASPECTS IN HEMOPHILIA-A PATIENTS, Thrombosis and haemostasis, 77(2), 1997, pp. 298-302
Authors:
LINDEBERG S
BERNTORP E
CARLSSON R
ELIASSON M
MARCKMANN P
Citation: S. Lindeberg et al., HEMOSTATIC VARIABLES IN PACIFIC ISLANDERS APPARENTLY FREE FROM STROKEAND ISCHEMIC-HEART-DISEASE - THE KITAVA STUDY, Thrombosis and haemostasis, 77(1), 1997, pp. 94-98
Authors:
ZOLLER B
HILLARP A
BERNTORP E
DAHLBACK B
Citation: B. Zoller et al., ACTIVATED PROTEIN-C RESISTANCE DUE TO A COMMON FACTOR-V GENE MUTATIONIS A MAJOR RISK FACTOR FOR VENOUS THROMBOSIS, Annual review of medicine, 48, 1997, pp. 45-58
Authors:
ASTERMARK J
EKMAN M
BERNTORP E
Citation: J. Astermark et al., NO EFFECT OF A NEW 2ND-GENERATION B-DOMAIN-DELETED RECOMBINANT PRODUCT ON LYMPHOCYTE-TRANSFORMATION IN-VITRO - A STUDY OF PLASMA-DERIVED AND RECOMBINANT PRODUCTS, British Journal of Haematology, 99(2), 1997, pp. 289-294
Authors:
LEITERMANN K
BERNTORP E
EWENSTEIN BM
SOMMER S
THOMPSON AR
RUP BJ
Citation: K. Leitermann et al., MONITORING IGE AND IGG SUBCLASSES IN HEMOPHILIA-B PATIENTS WITH FACTOR-IX (FIX) INHIBITORS, Blood, 90(10), 1997, pp. 145-145
Authors:
LINDEBERG S
BERNTORP E
NILSSONEHLE P
TERENT A
VESSBY B
Citation: S. Lindeberg et al., AGE RELATIONS OF CARDIOVASCULAR RISK-FACTORS IN A TRADITIONAL MELANESIAN SOCIETY - THE KITAVA STUDY, The American journal of clinical nutrition, 66(4), 1997, pp. 845-852